Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Salmeterol/Fluticasone Propionate vs Ipratropium/Albuterolin Chinese Patients With Moderate-to-severe COPD.

NCT01243788 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT01243788
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01243788 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Salmeterol/Fluticasone Propionate vs Ipratropium/Albuterolin Chinese Patients With Moderate-to-severe COPD.
Lead sponsor
Fudan University
Phase
Phase 4
Overall status
Unknown status
Start date
July 31, 2009
Completion date
October 31, 2011
Enrollment
450 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease (copd)